FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 117867011 | Neomycin sulfate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 501730016 | Neomycin sulphate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 811074015 | Neomycin sulfate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neomycin sulfate | Is a | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
| Neomycin sulfate | Is a | Bactericide | false | Inferred relationship | Some | ||
| Neomycin sulfate | Is a | Neomycin (substance) | false | Inferred relationship | Some | ||
| Neomycin sulfate | Is a | Substance with aminoglycoside structure and antibacterial mechanism of action (substance) | true | Inferred relationship | Some | ||
| Neomycin sulfate | Is modification of (attribute) | Neomycin (substance) | true | Inferred relationship | Some | ||
| Neomycin sulfate | Has disposition (attribute) | Antibacterial (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has precise active ingredient | True | Neomycin sulfate | Inferred relationship | Some | 3 |
| Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has basis of strength substance (attribute) | True | Neomycin sulfate | Inferred relationship | Some | 3 |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has precise active ingredient | True | Neomycin sulfate | Inferred relationship | Some | 3 |
Start Page 2 of 2
This concept is not in any reference sets